OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
October 03, 2022
External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.
Standardized risk assessment and analysis protocols facilitate the comparison of processing equipment components.
BFS technology can help maintain sterility during the biologics manufacturing process.
Various advances in contamination control are being utilized to reduce the chance pollutants contaminate a drug product.
October 02, 2022
Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.
A blended approach to newly revised regulatory guidance to inform environmental monitoring programmes is essential.
Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.
FDA backs joint reviews, common research policies, and modern production methods around the world.
ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.
The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.